Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational studyBenedict Lim Heng Sim, Pik Pin Goh, Suresh Kumar Chidambaram et al.|The Lancet Regional Health - Western Pacific|2020Cited by 132
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesSteven Lim, Sangeetha Jaya Selan, Chee Peng Hor et al.|JAMA Internal Medicine|2022Cited by 105
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical TrialChuan Huan Chuah, Bai Han Ooi, Ting Soo Chow et al.|Clinical Infectious Diseases|2021Cited by 47
Clinical Characteristics and Risk Factors for Severe COVID-19 infections in MalaysiaXin Ci Wong, Benedict Lim Heng Sim, Chee Peng Hor et al.|Zenodo (CERN European Organization for Nuclear Research)|2020Cited by 0